DNLI News and Press, Denali Therapeutics Inc. From 01/29/26

Hunter syndrome (MPS II) presentations will include analysis from continued follow-up of Phase 1/2 data for tividenofusp alfa (DNL310), currently under FDA Priority Review Preliminary data from Phase 1/2 study of DNL126 (ETV:SGSH) for Sanfilippo syndrome type A (MPS IIIA) to be featured in oral ...

2026-01-14 00:45:58 ET Denali Therapeutics Inc. (DNLI) 44th Annual J.P. Morgan Healthcare Conference January 13, 2026 4:30 PM EST... Read the full article on Seeking Alpha For further details see: Denali Therapeutics Inc. (DNLI) Presents at 44th Annual J.P. Morgan Healthcare...

Preparing for FDA approval and commercial launch of tividenofusp alfa, Denali’s TransportVehicle™ (TV)-enabled investigational therapy for Hunter syndrome Expecting multiple clinical data readouts from pipeline programs including for Sanfilippo syndrome Type A (ETV:SGSH), granulin-...

Tividenofusp alfa treatment showed reduction and normalization in key disease biomarkers, stabilization or improvement in clinical endpoints including adaptive behavior, cognition and hearing, and normalization of liver volume  Most common treatment-related adverse events were infusion-re...

2025-12-16 16:23:10 ET More on iShares Russell 3000 ETF IWV: Derisking By Broadening Exposure To The Wider Market Goldman's 30 stocks with signs of froth Seeking Alpha’s Quant Rating on iShares Russell 3000 ETF Dividend scorecard for iShares Russell 30...

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The longevity economy is entering a massive repricing event as researchers confirm that metabolic dysfunction in early adulthood leaves measurable markers of brain aging ...

2025-12-13 04:33:24 ET Introduction Eli Lilly ( LLY ) has generated their Keytruda/Humira moment. A generation-defining medicine that in fact owns a duopoly, for the time being, with Novo Nordisk ( NVO ). Cash flows for the next few years will be immense but will become ...

2025-12-10 16:58:18 ET Wednesday finally broke the logjam that the stock market had been in earlier in the week, as the Federal Reserve's two-day meeting on interest rates finally ended. Fed Chair Jerome Powell announced a quarter-percentage-point cut in the Federal Funds rate to a new rang...

2025-12-10 14:47:27 ET The last time I spoke about Denali Therapeutics Inc. ( DNLI ) it was with respect to a Seeking Alpha article entitled "Denali: Despite ALS Primary Endpoint Failure, Possible Path Forward Remains." With respect to this article, I went over that the company ...

2025-12-10 05:34:17 ET More on Denali Therapeutics Denali Therapeutics Inc. (DNLI) Analyst/Investor Day Transcript Denali Therapeutics Inc. (DNLI) Analyst/Investor Day - Slideshow Denali: Regulatory Delay Is A Strategic Opportunity Denali Therapeutics prices ...